1. Home
  2. BLIN vs QNRX Comparison

BLIN vs QNRX Comparison

Compare BLIN & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgeline Digital Inc.

BLIN

Bridgeline Digital Inc.

HOLD

Current Price

$1.15

Market Cap

12.9M

Sector

Technology

ML Signal

HOLD

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$4.34

Market Cap

11.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLIN
QNRX
Founded
2000
2018
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9M
11.6M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
BLIN
QNRX
Price
$1.15
$4.34
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.62
N/A
AVG Volume (30 Days)
70.7K
295.6K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,568,000.00
N/A
Revenue This Year
$22.67
N/A
Revenue Next Year
$21.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$3.25
52 Week High
$1.74
$41.80

Technical Indicators

Market Signals
Indicator
BLIN
QNRX
Relative Strength Index (RSI) 61.58 46.31
Support Level $0.77 $4.25
Resistance Level $1.30 $5.15
Average True Range (ATR) 0.10 0.64
MACD -0.00 0.01
Stochastic Oscillator 87.36 60.00

Price Performance

Historical Comparison
BLIN
QNRX

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: